BACKGROUND Screening overweight and obese children for non-alcoholic fatty liver disease (NAFLD) is recommended by paediatric and endocrinology societies. However, gastroenterology societies have called for more data before making a formal recommendation. AIM To determine whether the detection of suspected NAFLD in overweight and obese children through screening in primary care and referral t...

BACKGROUND Liver disease continues to be a major cause of morbidity and mortality in sub-Saharan Africa, including Nigeria, due to the high endemicity of viral hepatitis B. However non-alcoholic fatty liver disease may be an important contributory factor. The impact of fatty liver disease in our region has not been evaluated. AIM To determine the prevalence of non-alcoholic fatty liver diseas...

Non-alcoholic fatty liver disease (NAFLD) is becoming increasingly prevalent due to the worldwide obesity epidemic and currently affects one-third of adults or about one billion people worldwide. NAFLD is predicted to affect over 50% of the world's population by the end of the next decade. It is the most common form of liver disease and is associated with increased risk for progression to a mor...

Submit Manuscript | http://medcraveonline.com Abbreviations: ALT: Alanine Amino Transferases; AST: Aspartate Amino Transferases; AUROC: Area Under the Receiver Operating Characteristic Curve; BMI: Body Mass Index; CIT: Cold Ischemia Time; CT: Computed Tomography; D-MELD: Donor Age Multiplied with the Recipient Model for End-Stage Liver Disease; ECD: Extended Criteria Donor; EGD: Early Graft Dys...

Non-alcoholic fatty liver disease (NAFLD) is an emerging public health problem globally. NAFLD one of the most common diseases worldwide and cause abnormal enzymes in many developed countries. estimated to afflict approximately 1 billion individuals worldwide. An 20-30 % general population afflicted from it In India could be a silent epidemic with its prevalence ranging 9-32%. Studies have show...

Background: Fatty liver disease has been associated with increased levels of various circulating inflammatory markers. Difference in the level markers between patients AFLD and NAFLD is still unclear. Aim & Objectives: The aim present study was to compare alcoholic-fatty (AFLD) non-alcoholic fatty (NAFLD) also see if any correlation exists enzymes. Materials Methods: This conducted on 70 (3...

BACKGROUND Non-alcoholic fatty liver disease (NAFLD) is the most common hepatic disorder, which poses a significant health burden in the western countries. As the epidemic of obesity slides health downward, the incidence of NAFLD is evidently increasing. AIM We aimed to ascertain the awareness of NAFLD and its risk factors in the general population, which may be helpful in designing education...

metabolome analysis is used to evaluate the characteristics and interactions of low molecular weight metabolites under a specific set of conditions. in cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease (nafld) and non-alcoholic steatotic hepatitis (nash) the  liver  does not function thoroughly due to long-term damage. unfortunately the early detection of cirrhosis, hcc, na...

the epidemic of obesity and associated features of metabolic syndrome including NASH (non-alcoholic steatohepatitis) and NAFld (non-alcoholic fatty liver disease) is spreading worldwide; thanks to the increasingly sedentary life style! it is estimated that 12-15% of the global population is affected with NAFld; 50% of diabetics develop NAFld. it is seen in 57-74% of obese persons and the preval...

Non-Alcoholic Fatty Liver Disease (NAFLD) is termed as the accumulation of extra fat in hepatic cells and it is mainly associated with obesity and insulin resistance [1]. NAFLD is very common in the general population and almost up to 29% of the adults are documented with excessive fat accumulation in the liver [2]. NAFLD encompasses a histological spectrum ranging from simple steatosis to non-...